Additional Remarks definition

Additional Remarks. REFERRING BROKER: RECIPIENT BROKER: (Broker name) (Broker name) License No. State: Exp: License No.: State: NV Exp: Signature: Signature: Date: Date: REFERRING AGENT: RECIPIENT AGENT: Name: Name: License No. State: Exp: License No: State: Exp: Signature: Signature: Date: Date: THIS REFERRAL AGREEMENT IS NOT VALID UNLESS IT IS SIGNED BY THE BROKERS. Commissions payable for the sale, purchase, exchange, option or lease of property are not set, fixed, controlled, suggested, maintained or recommended by any Board or Association of REALTORS®, Commercial Information Exchange or Multiple Listing Service or in any manner other than as negotiated between brokers. THIS FORM HAS BEEN APPROVED BY THE GREATER LAS VEGAS ASSOCIATION OF REALTORS® (GLVAR). NO REPRESENTATION IS MADE AS TO THE LEGAL VALIDITY OR ADEQUACY OF ANY PROVISION IN ANY SPECIFIC TRANSACTION. A REAL ESTATE BROKER IS THE PERSON QUALIFIED TO ADVISE ON REAL ESTATE TRANSACTIONS. IF YOU DESIRE LEGAL OR TAX ADVICE, CONSULT AN APPROPRIATE PROFESSIONAL.
Sample 1Sample 2
Additional Remarks. (please provide any additional information that may help in processing your request)   To be completed by SC dhec authorized personnel only
Sample 1
Additional Remarks. This Patent License Agreement, hereinafter referred to as the "
Sample 1

Examples of Additional Remarks in a sentence

  • Additional Remarks: Customer: Company: Date: Date: Signature: Signature: ANNEX The fees and services in this contract will be only applicable for the selected subscription package.

  • Additional Remarks: Company: Customer: Date: Date: Signature: Signature: ANNEX 1 The fees and services in this contract will be only applicable for the selected subscription package.

  • Additional Remarks In a conflict situation between any parties, the PAC must try to resolve it.

  • E.L. DISEASE - EA EMPLOYEE $ (Mandatory in NH) If yes, describe under E.L. DISEASE - POLICY LIMIT $ DESCRIPTION OF OPERATIONS below DESCRIPTION OF OPERATIONS / LOCATIONS / VEHICLES (XXXXX 101, Additional Remarks Schedule, may be attached if more space is required) Mississippi Dept of Human Services is named additional insured w/respect to General Liablity when required by written contract.

  • Sharing of personal items Cleanliness/Cleaning Responsibilities Noise/Study Times Food/Shopping Smoking/Drinking/Drugs Parties/Entertaining Overnight Guests Additional Remarks: attach additional sheets if necessary This agreement is intended to promote harmony between roommates by clarifying the expectations and responsibilities of roommates to each other.

  • N (Mandatory in NH) If yes, describe under DESCRIPTION OF OPERATIONS below N / A WC485843100 07/01/2016 05/01/2017 PER STATUTE OTH- ER E.L. EACH ACCIDENT $1,000,000 E.L. DISEASE - EA EMPLOYEE $1,000,000 E.L. DISEASE - POLICY LIMIT $1,000,000 DESCRIPTION OF OPERATIONS / LOCATIONS / VEHICLES (XXXXX 101, Additional Remarks Schedule, may be attached if more space is required) Evidence of insurance.

  • N (Mandatory in NH) If yes, describe under DESCRIPTION OF OPERATIONS below N / A CWC1230994 AZ NM TX AK 12/15/2014 12/08/2015 X PER STATUTE OTH- ER E.L. EACH ACCIDENT $ 1,000,000 E.L. DISEASE - EA EMPLOYEE $ 1,000,000 E.L. DISEASE - POLICY LIMIT $ 1,000,000 A Property CCI 1230994 12/15/2014 12/15/2015 Property Scheduled DESCRIPTION OF OPERATIONS / LOCATIONS / VEHICLES (XXXXX 101, Additional Remarks Schedule, may be attached if more space is required) Proof of coverage regarding RFP 2015-002C.

  • E.L. DISEASE - EA EMPLOYEE $ 1,000,000 (Mandatory in NH) If yes, describe under E.L. DISEASE - POLICY LIMIT $ 1,000,000 DESCRIPTION OF OPERATIONS below DESCRIPTION OF OPERATIONS / LOCATIONS / VEHICLES (XXXXX 101, Additional Remarks Schedule, may be attached if more space is required)The County of Xxxxx, its officials, officers & employees are additional insured as respects General Liability & Automobile Liability; Primary & Non-Contriabutory - when required by written contract.

  • Additional Remarks: With this type of construction the client/homeowner understands that there exists the possibility of further discovery showing more extensive damage to the home.

  • Y (Mandatory in NH) If yes, describe under DESCRIPTION OF OPERATIONS below N / A PER STATUTE OTH- ER $ E.L. EACH ACCIDENT $ E.L. DISEASE - EA EMPLOYEE $ E.L. DISEASE - POLICY LIMIT $ DESCRIPTION OF OPERATIONS / LOCATIONS / VEHICLES (XXXXX 101, Additional Remarks Schedule, may be attached if more space is required) Mentoring Plus…Changing Lives One Good Student At a Time.


More Definitions of Additional Remarks

Additional Remarks. The terms of this AGREEMENT shall be considered CONFIDENTIAL. Public Benefit(s): The principal benefit of this invention is its potential to treat diseases of hormonal or endocrine tissues. This exclusive patent license agreement (hereinafter referred to as the ("AGREEMENT"), made effective the first date upon which all the Parties have subscribed their signatures hereunto ("EFFECTIVE DATE"), consists of this Cover Page, an attached AGREEMENT, a Signature Page, Appendix A (List of Patent(s) and/or Patent Application(s)), Appendix B (LICENSED FIELDS-OF-USE and LICENSED TERRITORY), Appendix C (Royalties), Appendix D (Modifications), Appendix E (BENCHMARKS), and Appendix F (COMMERCIAL DEVELOPMENT PLAN). The Parties to this AGREEMENT are:
Sample 1
Additional Remarks. (1) For U.S. Patent No. 5,366,977, entitled "Methods of Treating Cystic Fibrosis Using 8-Cyclopentyl-1,3-Dipropylxanthine or Xanthine Amino Congeners": exclusively for the treatment of cystic fibrosis and (2) For U.S. Patent Application Serial No. 08/343,714, filed November 22, 1994, entitled "A Method of Identifying CFTR-Binding Compounds Useful for Activating Chloride Conductance in Animal Cells": (i) exclusively for the treatment and diagnosis of cystic fibrosis in humans; (ii) exclusively for the class of compounds claimed for therapeutic and diagnostic uses for human diseases other than cystic fibrosis conditionally for a period of twenty-four (24) months; and (iii) nonexclusively for methods for identifying CFTR-binding compounds. This Patent License Agreement, hereinafter referred to as the "Agreement," consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Modifications), Appendix E (Benchmarks), and Appendix F (Commercial Development Plan). The Parties to this Agreement are:
Sample 1

Related to Additional Remarks

  • Final Remarketing means any Remarketing of the Notes that occurs during the Final Remarketing Period by the Remarketing Agent(s) pursuant to the Remarketing Agreement.

  • Failed Remarketing has the meaning specified in Section 5.4(b)(ii).

  • Successful Remarketing means, as applicable, a Successful Optional Remarketing or a Successful Final Remarketing.

  • Failed Remarketing Condition means a Failed Remarketing Condition-Purchased VRDP Shares or a Failed Remarketing Condition-Unpurchased VRDP Shares.

  • Subsequent Reset Rate of Interest means, in respect of any Subsequent Reset Period and subject to Condition 4(b)(ii), the rate of interest determined by the Calculation Agent on the relevant Reset Determination Date as the sum of the relevant Mid-Swap Rate and the relevant Subsequent Margin.

  • Accumulation Period Length means 12 months; provided, however, if the commencement of the Accumulation Period is delayed in accordance with Section 2.11 hereof, the Accumulation Period Length shall be determined in accordance with the definition of “Accumulation Period Length” in the Indenture Supplement.

  • Interest Payment Determination Date means the Interest Accrual Period End Date at the end of each Interest Accrual Period; provided that the Interest Payment Determination Date with respect to the final Interest Accrual Period will be the Rate Cut-off Date.

  • Payment Determination Date means, with respect to any Payment Date, one (1) Business Day immediately preceding such Payment Date.

  • Tax Event Repayment Date means the date set out in a notice from the Issuer to the Bondholders pursuant to Clause 10.4 (Early redemption option due to a tax event).

  • Early Amortization Event means any Early Amortization Event specified in Section 5.01 of the Indenture.

  • Liquidity Provider Ratings Event Termination Date means the date established by the Tender and Paying Agent, acting upon instructions of the Fund pursuant to the Tender and Paying Agent Agreement, for termination of the VRDP Purchase Agreement upon the occurrence of a Liquidity Provider Ratings Event, which date shall be not less than 16 days nor more than 30 days following such Liquidity Provider Ratings Event.

  • Monthly Report Determination Date The meaning specified in Section 10.7(a).

  • Event Determination Date means either:

  • Non-Lead Securitization Determination Date means the “determination date” (or any term substantially similar thereto) as defined in the related Non-Lead Securitization Servicing Agreement.

  • Periodic Term SOFR Determination Day has the meaning specified in the definition of “Term SOFR”.

  • Interest Rate Determination Date means, with respect to any Interest Period, the date that is two Business Days prior to the first day of such Interest Period.

  • Interest Determination Date means, with respect to a Rate of Interest and Interest Accrual Period, the date specified as such hereon or, if none is so specified, (i) the first day of such Interest Accrual Period if the Specified Currency is Sterling or (ii) the day falling two Business Days in London for the Specified Currency prior to the first day of such Interest Accrual Period if the Specified Currency is neither Sterling nor euro or (iii) the day falling two TARGET Business Days prior to the first day of such Interest Accrual Period if the Specified Currency is euro.

  • Termination Fee Event has the meaning ascribed thereto in Section 5.2(a);

  • Extension Determination Date means, in respect of a Series of Covered Bonds, the date falling two Business Days after the expiry of seven days from (and including) the Final Maturity Date of such Covered Bonds.

  • Controlled Accumulation Period Length has the meaning specified in subsection 4.03(c).

  • Accretion Termination Date As defined in the Series Supplement.

  • Reset Interest Determination Date means, in respect of any Reset Period, the day falling two Business Days prior to the beginning of the relevant Reset Period;

  • SOFR Interest Determination Date means the day that is the number of U.S. Government Securities Business Days prior to the Interest Payment Date in respect of the relevant Interest Period, as specified in the applicable Pricing Supplement.In addition to the Interest Periods and the Interest Payment Dates, the applicable Pricing Supplement shall specify and describe, as applicable, any relevant interest commencement date, interest period end date, interest determination date, index maturity, rate cut-off date, any other terms relating to the particular method of calculating interest on the Average SOFR Note (including any applicable payment delay, lockout or suspension period, lookback or observation shift) and any other terms applicable specifically to such Average SOFR Note.Term SOFR NotesUnless otherwise provided for or modified in the applicable Pricing Supplement, Term SOFR Notes will bear interest at a rate per annum equal to Term SOFR (as defined below) (or Specified-Tenor Term SOFR (as defined below)), plus the Spread.

  • Subsequent Rate Period means, with respect to any Series of RVMTP Shares, the period consisting of seven calendar days, but adjusted in each case to reflect any changes when the regular calendar day that is a Rate Determination Date is not a Business Day, from, and including, the first calendar day following the Initial Rate Period of such Series to, and including, the next Rate Determination Date for such Series and any period thereafter from, and including, the first calendar day following a Rate Determination Date for shares of such Series to, and including, the next succeeding Rate Determination Date for shares of such Series.

  • Failed Remarketing Condition—Purchased VRDP Shares Redemption means redemption by the Fund, at a Redemption Price equal to $100,000 per share plus accumulated but unpaid dividends thereon (whether or not earned or declared) to, but excluding, the date fixed by the Board of Directors for redemption, of VRDP Shares that the Liquidity Provider shall have acquired pursuant to the Purchase Obligation and continued to be the beneficial owner of for federal income tax purposes for a period of six months during which such VRDP Shares cannot be successfully remarketed (i.e., a Failed Remarketing Condition--Purchased VRDP Shares shall have occurred and be continuing for such period of time with respect to such VRDP Shares), determined by the Fund on a first-in, first-out basis, in accordance with and subject to the provisions of the VRDP Fee Agreement and this Statement.